A new drug discovery system allows scientists to specifically target members of an important family of enzymes, called phosphatases, which were previously considered mostly “undruggable”.
26 July, 2018
Related intellectual property exclusively licensed to PureTech Health and being advanced as part of growing internal research and development division
25 July, 2018
Scientists at the University of Birmingham, UK, are one step closer to developing an eye drop that could revolutionise treatment for age-related macular degeneration (AMD).
20 July, 2018